Non Medullary Thyroid Carconoma Nmtc clinical trials

Explore recruiting non medullary thyroid carconoma nmtc clinical trials.

Also recruiting in Europe

Non Medullary Thyroid Carconoma Nmtc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Digoxin for the Reinduction or Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma.

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Non Medullary Thyroid Carconoma Nmtc trials by city

Non Medullary Thyroid Carconoma Nmtc in Toronto Non Medullary Thyroid Carconoma Nmtc in Vancouver Non Medullary Thyroid Carconoma Nmtc in Montreal Non Medullary Thyroid Carconoma Nmtc in Calgary Non Medullary Thyroid Carconoma Nmtc in Edmonton Non Medullary Thyroid Carconoma Nmtc in Ottawa Non Medullary Thyroid Carconoma Nmtc in Winnipeg Non Medullary Thyroid Carconoma Nmtc in Quebec City Non Medullary Thyroid Carconoma Nmtc in Hamilton Non Medullary Thyroid Carconoma Nmtc in Kitchener Non Medullary Thyroid Carconoma Nmtc in London Non Medullary Thyroid Carconoma Nmtc in Halifax Non Medullary Thyroid Carconoma Nmtc in New York Non Medullary Thyroid Carconoma Nmtc in Los Angeles Non Medullary Thyroid Carconoma Nmtc in Chicago Non Medullary Thyroid Carconoma Nmtc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease